BIOANALYSIS OF LARGE MOLECULES

Swiss BioQuant specializes in developing and validating highly sensitive and specific immunoassays for quantifying peptide and protein therapeutics (biopharmaceuticals), oligonucleotides, and nanoparticles across various biological matrices. 

Our services include:

• Quantification of drug levels
• Determination of anti-drug antibodies (ADA)
• Investigation of ADA neutralization activities (NAB)
• Biomarker characterization
• PK/TK analysis
• Enzymatic activity
• Cell-based assays
• qPCR